Research on pharmacokinetics during pregnancy

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Reproductive Pharmacology
• Clinical Pharmacy

Background:

• Understanding drug pharmacokinetics during pregnancy is crucial for safe and effective treatment.
• Physiological changes during pregnancy and labor significantly alter drug disposition.
• Limited data exists on the comparative pharmacokinetic profiles of various essential drugs in pregnant and laboring women.

Purpose of the Study:

• To investigate the pharmacokinetic changes of key drugs during the third stage of pregnancy and labor.
• To compare drug elimination half-lives between pregnant, laboring, and non-pregnant women.
• To identify how elimination pathways and biotransformation rates influence these pharmacokinetic alterations.

Main Methods:

• Comparative pharmacokinetic study involving pregnant women (stage III), women in labor, and a non-pregnant control group.
• Analysis of drug elimination half-life for noramidopyrine methane sulphonate sodium, aminophenyzone, pethidine, methaqualone, ampicillin, cephalothin, chlorsulfamethin, and indocyanine green.
• Correlation of observed pharmacokinetic changes with drug elimination routes and biotransformation rates.

Main Results:

• Most studied drugs exhibited a prolonged elimination half-life during labor compared to non-pregnant controls.
• The half-life of most drugs was found to be diminished during pregnancy.
• Cephalothin was an exception, showing no significant half-life prolongation during labor.

Conclusions:

• Drug pharmacokinetics, specifically elimination half-life, are significantly altered in pregnant and laboring women.
• These alterations are drug-specific and influenced by individual elimination pathways and metabolic rates.
• Findings underscore the need for careful drug dosage adjustments and monitoring in obstetric pharmacotherapy.